ARCHIVES

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

NCI And SPORE PIs Discussing Potential Changes To Grant Program Guidelines.

September 19, 2008

DCT Advisors Approve Increased Spending On Trials Monitoring

May 6, 1994

Biomedical Research Advocates Temper Budget Requests In View Of War, Deficit.

January 28, 2005

GAO Recommends Tighter Policies on NIH Recusals.

June 29, 2007

Advisers Fume Over Preventions Budget Cut; NIH Probably Did It

May 22, 1992

FCRC Committee Limited To Review Of Basic Science

November 26, 1976